Pathways2Rx™ reveals deep insights into the diagnosis and treatment pathway of a disease, identifying new and hidden growth opportunities for your brand.
Among our integrated offerings, Pathways2Rx bridges rich insights gleamed from qualitative market research with statistically sound quantitative data gathered from both primary and secondary sources. By studying all the stakeholders, including: physicians, other healthcare providers and patients, we are able to examine all possible points of entry and exit for a prescription drug as the patient moves from first becoming aware of a potential health problem through to ongoing disease management.
As illustrated in the following infographic this process is continuous, following the patient from the point of diagnosis and treatment through to filling of the prescription, patient compliance and follow up, thereby identifying possible leakage points beyond the initial script.
Building upon these findings it is then possible to add further depth by incorporating data gathered from secondary sources, such as prescription drug sales or disease prevalence rates among the general population, and to forecast a potential value for each identified opportunity. The resulting calculation serves to prioritize these potential opportunities, thereby driving the brand’s marketing strategy.
In summary, Pathways2Rx is an integrated marketing research solution that seeks to uncover key opportunities for new brands, or to further market share of an existing brand, by isolating points of leakage, untapped markets and identifying sources of influence along the diagnosis and treatment pathway. This service is essential for new product launches and for mature brands seeking hidden growth opportunities.